These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9096189)

  • 1. Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics.
    Gui GP; Thomas PR; Tizard ML; Lake J; Sanderson JD; Hermon-Taylor J
    J Antimicrob Chemother; 1997 Mar; 39(3):393-400. PubMed ID: 9096189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease.
    Shafran I; Kugler L; El-Zaatari FA; Naser SA; Sandoval J
    Dig Liver Dis; 2002 Jan; 34(1):22-8. PubMed ID: 11930899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease.
    Selby W; Pavli P; Crotty B; Florin T; Radford-Smith G; Gibson P; Mitchell B; Connell W; Read R; Merrett M; Ee H; Hetzel D;
    Gastroenterology; 2007 Jun; 132(7):2313-9. PubMed ID: 17570206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe Crohn's disease using antimycobacterial triple therapy--approaching a cure?
    Borody TJ; Leis S; Warren EF; Surace R
    Dig Liver Dis; 2002 Jan; 34(1):29-38. PubMed ID: 11926571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open label trial of oral clarithromycin in active Crohn's disease.
    Leiper K; Morris AI; Rhodes JM
    Aliment Pharmacol Ther; 2000 Jun; 14(6):801-6. PubMed ID: 10848665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial of clarithromycin and ethambutol in the treatment of Crohn's disease.
    Goodgame RW; Kimball K; Akram S; Ike E; Ou CN; Sutton F; Graham D
    Aliment Pharmacol Ther; 2001 Dec; 15(12):1861-6. PubMed ID: 11736715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined azithromycin and metronidazole therapy is effective in inducing remission in pediatric Crohn's disease.
    Levine A; Turner D
    J Crohns Colitis; 2011 Jun; 5(3):222-6. PubMed ID: 21575885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of the Australian Crohn's disease antibiotic study.
    Chamberlin W
    Gastroenterology; 2007 Nov; 133(5):1744-5; author reply 1745-6. PubMed ID: 17983827
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trial: randomized study of clarithromycin versus placebo in active Crohn's disease.
    Leiper K; Martin K; Ellis A; Watson AJ; Morris AI; Rhodes JM
    Aliment Pharmacol Ther; 2008 Jun; 27(12):1233-9. PubMed ID: 18315579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Australian antibiotic trial in Crohn's disease: alternative conclusions from the same study.
    Kuenstner JT
    Gastroenterology; 2007 Nov; 133(5):1742-3; author reply 1745-6. PubMed ID: 17983824
    [No Abstract]   [Full Text] [Related]  

  • 12. Open label trial of clarithromycin therapy in Japanese patients with Crohn's disease.
    Inoue S; Nakase H; Matsuura M; Ueno S; Uza N; Kitamura H; Mikami S; Tamaki H; Kasahara K; Chiba T
    J Gastroenterol Hepatol; 2007 Jul; 22(7):984-8. PubMed ID: 17608842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of Crohn's disease following corticosteroid-induced remission.
    Papi C; Festa V; Leandro G; Moretti A; Tanga M; Koch M; Capurso L
    Am J Gastroenterol; 2007 Apr; 102(4):814-9. PubMed ID: 17222316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for the prevention of mycobacterium avium complex in adults and children with HIV.
    Uthman MM; Uthman OA; Yahaya I
    Cochrane Database Syst Rev; 2013 Apr; (4):CD007191. PubMed ID: 23633339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimycobacterial therapy in Crohn's disease: game over?
    Peyrin-Biroulet L; Neut C; Colombel JF
    Gastroenterology; 2007 Jun; 132(7):2594-8. PubMed ID: 17570230
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-TNF therapy in treatment of luminal Crohn's disease].
    Marko B; Prka L
    Acta Med Croatica; 2013 Apr; 67(2):179-89. PubMed ID: 24471301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
    Charpignon C; Beau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):153-7. PubMed ID: 18343615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's disease in clinical practice.
    Ampuero J; Rojas-Feria M; Castro-Fernández M; Millán-Lorenzo M; Guerrero-Jiménez P; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Jan; 31(1):112-8. PubMed ID: 26173493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003459. PubMed ID: 15674908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uveitis in a patient receiving rifabutin for Crohn's disease.
    Awotesu O; Missotten T; Pitcher MC; Lynn WA; Lightman S
    J R Soc Med; 2004 Sep; 97(9):440-1. PubMed ID: 15340029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.